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Abstract
Introduction: Type	2	diabetes	(T2D)	is	multifactorial	involving	lifestyle,	environmental	
and genetic risk factors. This study aims to investigate the impact of genetic interac‐
tions	with	alcohol	and	diet	quality	on	glycated	haemoglobin	A1c	(HbA1c)	independent	
of obesity, in a British population.
Methods: Cross‐sectional	study	of	14	089	white	British	participants	 from	Airwave	
Health	Monitoring	Study	and	a	subsample	of	3733	participants	with	dietary	data.	A	
T2D	genetic	risk	score	(GRS)	was	constructed,	and	its	interactions	with	diet	on	HbA1c	
were assessed.
Results: GRS	was	associated	with	a	higher	HbA1c%	(β = 0.03, P	<	0.0001)	and	a	higher	
risk	 of	 prediabetes	 (OR	=	 1.09,	P	 <	 0.0001)	 and	T2D	 (OR	=	1.14,	P	 =	 0.006).	 The	
genetic	effect	on	HbA1c%	was	significantly	higher	 in	obese	participants	 (β = 1.88, 
Pinteraction	=	0.03).	A	high	intake	of	wholegrain	attenuated	the	effect	on	HbA1c%	in	
high‐risk	individuals	Pinteraction = 0.04.
Conclusion: The	genetic	effect	on	HbA1c	was	almost	doubled	in	obese	individuals,	
compared with those with a healthy weight, and independent of weight, there was 
a	modest	offset	on	HbA1c	 in	high‐genetic‐risk	 individuals	consuming	a	diet	high	 in	
wholegrain. This supports the importance of a healthy diet high in wholegrains and 
along	with	maintaining	a	healthy	weight	in	controlling	HbA1c	among	high‐genetic‐risk	
groups.
K E Y W O R D S
diet, genetic risk, type 2 diabetes
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1  | INTRODUC TION
Worldwide over 382 million people are estimated to have type 2 di‐
abetes	 (T2D).1	 People	with	T2D	have	a	 fivefold	 risk	 in	developing	
cardiovascular	 disease	 (CVD)	 and	 are	 1.6	 times	more	 likely	 to	 die	
prematurely, compared with those without T2D.2 Early intervention 
at the critical stage, prediabetes may halt the development of T2D 
and	further	reduce	the	risk	of	CVD	and	related	premature	mortality	
worldwide.1
The aetiology of T2D is multifactorial, with obesity, poor diet 
quality, physical inactivity and genetic factors identified as key risk 
factors.2	Genome‐wide	association	studies	(GWAS)	have	identified	
over	80	T2D‐associated	loci	3,4 of which 70 loci are associated with 
glycaemic trait5,6; most of these are not associated with obesity 
markers.	Single	nucleotide	polymorphisms	(SNP)	have	small‐to‐mod‐
erate effects and account for only a small proportion of the herita‐
bility of T2D.3,7,8	To	increase	the	predictability,	SNPs	are	combined	
into genetic risk scores.
Lifestyle	factors	such	as	diet,	alcohol	and	weight	are	modifiable	
key components in the development of T2D.2	Although	 response	
to diet is variable, emerging evidence suggests that these lifestyle 
factors may modify the genetic effect on development of T2D.9‐11 
Dayeh et al10	showed	epigenetic	changes	in	over	853	T2D‐related	
genes	 (1649	 CpG	 sites)	 associated	 with	 age	 and	 environmental	
factors	 (physical	 activity,	 adiposity),	 resulting	 in	 modifications	 to	
various	 glycaemic	 traits.	 The	 US	 National	 Health	 and	 Nutrition	
Examination	Surveys	found	that	the	genetic	effect	on	T2D	outcome	
was	modified	(reduced)	in	individuals	with	a	diet	high	intake	of	car‐
bohydrates and fibre.12	 Most	 interaction	 dietary	 studies	 to	 date	
have only looked at genetic effects and single nutrients derived 
from food frequency questionnaires.13	 EPIC‐InterAct	 highlighted	
the	importance	of	studying	the	combined	effect	of	these	SNPs	as	
a	genetic	risk	scores	(GRS)	for	T2D	yet;	no	interactions	were	found	
with any single nutrients.14	However,	evidence	suggests	modifica‐
tion of diabetes risk factors is related to a profile of diet quality 
rather single nutrients.15 There is a need for a more comprehensive 
assessment	of	high‐quality	diet	data,	dietary	profiling	with	genetic	
interactions	on	risk	of	T2D,	to	fully	understand	the	complexity	of	
dietary	intake	and	the	combined	effect	of	these	SNPs	as	genetic	a	
genetic risk score.
The aim of the study is to investigate associations between 
the	combined	effect	of	genetic	variants	and	HbA1c	among	a	white	
British population group, and if these associations are modified by 
interactions	with	lifestyle	factors	including	diet	quality	(dietary	pro‐
filing)	and	alcohol	independent	of	obesity	markers;	body	mass	index	
(BMI)	and	waist	circumference.
2  | METHODS
2.1 | Study design and participants
Members	of	 the	police	 forces	 in	Great	Britain	were	eligible	 for	 in‐
clusion	 in	the	Airwave	Health	Monitoring	Study.	Further	details	of	
the recruitment procedures and data collection methods have been 
described elsewhere.16 The present study comprises a random sam‐
ple of 14 089 white British participants who took part in a health 
screen, genetic testing and a subsample of 3733 participants who 
also	provided	dietary	data	between	2007	and	2012.	All	 biological	
sampling and dietary data were collected in the same period during 
participants first visit to the clinic.
2.2 | Ethics approval
Participants	provided	written	informed	consent,	and	the	study	had	
ethics	approval	from	the	National	Health	Service	Multi‐Site	Research	
Ethics	Committee	(MREC/13/NW/0588).
2.3 | Data collection
The	health	screenings	were	carried	out	in	dedicated	Airwave	Health	
Monitoring	Study	clinics	using	a	standard	protocol.	Trained	nurses	
conducted	all	clinical	examinations.
2.3.1 | Anthropometry
Height	 and	 sitting	 height	 were	 measured	 using	 a	 Marsden	 H226	
portable	stadiometer	and	weight	using	a	Marsden	digital	weighing	
scale.	Waist	 circumference	 was	measured	 using	 a	Wessex‐finger/
joint	measure	 tape	 (Seca	201;	 Seca).	 For	 all	 anthropometrics,	 two	
measurements were taken and the average was used.
2.3.2 | Blood samples
All	 samples	 were	 taken	 nonfasting.	 Tests	 were	 performed	 using	
serum	 samples	 except	HbA1c,	which	was	 performed	 using	whole	
EDTA	 blood	 sample	 and	 glucose	 determination,	 which	 was	 per‐
formed	using	fluoride/oxalate	sample	tube.	Samples	were	measured	
using	an	IL	650	analyser	(Instrumentation	Laboratory).
2.3.3 | DNA extraction and genotyping
Participants	 were	 genotyped	 using	 the	 Illumina	 HumanCore	
Exome‐12v1‐1	BeadChip	array	and	imputed	using	the	1000	Genomes	
phase	3	reference	panel	in	MiniMac.	For	this	analysis,	genotypes	for	
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the	SNPs	of	interest	were	assigned	based	on	the	highest	genotype	
probability	 if	 the	 SNP	was	 imputed.	 Additional	 quality	 control	 fil‐
ters	were	applied	to	the	included	SNPs	in	plink version 1.0717; 282 
participants	and	one	SNP	were	excluded	based	on	Hardy‐Weinberg	
equilibrium	(P	<	0.001),	minor	allele	frequencies	(MAF)	(<0.01),	SNP	
missingness	and	individual	missingness	rates	(<0.01).	Detailed	qual‐
ity control protocol is described in Supporting Information.
2.3.4 | Socio‐demographic
Health	 and	 lifestyle	 data	 were	 collected	 via	 a	 self‐administrated	
electronic questionnaire, which the participant completed during 
their	clinic	visit.	Variables	used	for	this	study	included	age,	gender,	
ethnicity, smoking status, diagnosed diseases, medication usage and 
physical	activity,	estimated	using	the	International	Physical	Activity	
Questionnaire	short	version.	The	metabolic	equivalent	of	task	(MET)	
in minutes per week was calculated for each participant and catego‐
rized	as	high	(at	least	60	minutes/d	of	at	least	moderate‐intensity	ac‐
tivity),	medium	(at	least	30	minutes/d	of	at	least	moderate‐intensity	
activity)	and	low	(no	activity	or	less	then	medium	category).18
2.4 | Dietary data
Dietary	intake	was	assessed	using	a	validated	7‐day	food	diary	(es‐
timated	 weight).19 Recorded dietary intakes were translated into 
nutrient intake data using dietplan	 software	 (Forestfield	 Software	
Ltd)	which	is	based	on	the	McCance	and	Widdowson's	6th	Edition	
Composition	 of	 Foods	 UK	 Nutritional	 Dataset	 (UKN).	 All	 dietary	
coders were trained by a research dietician/nutritionist using a 
study‐specific	operational	manual	protocol.	Detailed	description	of	
the coding and diet analysis is reported elsewhere.20
Overall	quality	of	dietary	intake	was	determined	by	the	UK	Dietary	
Reference	Value	index	(DRV).	The	DRV	index	is	an	a	priori	diet	quality	
index	that	reflects	adherence	to	the	UK	dietary	reference	values	and	
guidelines21 and has previously been shown to be negatively associ‐
ated	with	HbA1c,	waist	circumference	and	T2D.22	The	16‐point	DRV	
index	consists	of	eight	nutritional	components:	total	fat,	saturated	fat,	
sodium, fruit/vegetables, fibre, added sugar, total carbohydrates, fish 
(including	oily	fish).22 In short, mean daily intake of each of the eight 
components	 is	 assessed	and	 scored	according	 to	 the	UK	DRV.	The	
sum	of	the	total	points	provides	an	overall	score	between	0	and	16	
points; a higher score indicates a more favourable diet.
2.5 | SNP selection and genetic risk score
The	analysis	 included	87	common	SNPs	 (Table	S2)	 associated	with	
T2D	 and	 HbA1c	 in	 European‐descent	 populations	 extracted	 from	
164	SNPs	 identified	 in	 a	 systematic	 literature	 review	 in	databases,	
DIAbetes	 Genetics	 Replication	 And	 Meta‐analysis	 consortium	
(DIAGRAM)3	 and	 Meta‐Analyses	 of	 Glucose	 and	 Insulin‐related	
traits	Consortium	(MAGIC),4,6	and	from	the	National	Human	Genome	
Institute	Research	(NHGIR)	GWAS	catalogue.23 Systematic literature 
review	 is	detailed	 in	Supplementary	Material.	 SNPs	 in	high	 linkage	
disequilibrium	(r2	<	0.8)	were	excluded.	SNPs	located	in	obesity	gene	
FTO	(rs9939609,	rs8050136,	rs11642841,	rs8090011)	were	excluded	
given	the	well‐documented	association	with	obesity	which	mediates	
the effect on T2D risk. Diet interaction analyses were conducted for 
GRS	including	the	SNPs	in	FTO	gene	to	investigate	the	diet	role	when	
controlling	 for	 FTO	 SNPs.	 An	 unweighted	 poly‐genetic	 risk	 score	
(GRS)	was	constructed	in	PLINK	for	each	participant	by	summing	the	
number	of	risk	alleles	present	 (0	for	noncarrier,	1	for	heterozygous	
and	2	for	homozygous).	The	GRS	was	standardized	against	the	sample	
population's	standard	deviation	(SD)	for	appropriate	scaling	for	clini‐
cal	interpretation:	Standardized	(centred)	GRS	=	GRS/GRS	SD.
2.6 | Clinical definitions
Type	 2	 diabetes	was	 defined	 as	HbA1c	 ≥6.5%,	 diagnosed	 T2D	 or	
on	 glucose‐controlling	 medication.24	 Prediabetes	 was	 defined	 as	
HbA1c	between	5.7%	and	6.4%.25	BMI	was	calculated	as	weight	in	
kg	divided	by	the	square	of	height	 in	metres.	BMI	categories	were	
underweight	 (BMI	 <18.5	 kg/m2),	 healthy	 (18.5‐24.9	 kg/m2),	 over‐
weight	(25‐29.9	kg/m2)	and	obese	(≥30	kg/m2).
2.7 | Statistical analysis
Baseline	socio‐demographic	and	 lifestyle	characteristics	of	partici‐
pants	were	compared	across	GRS	tertiles	(T)	using	linear	regression	
for	continuous	variables	and	chi‐square	test	for	categorical	variables.
Association	between	the	GRS	and	HbA1c	was	analysed	via	mul‐
tivariable	linear	models.	Both	HbA1c	and	GRS	followed	a	normal	sta‐
tistical	distribution.	Models	were	adjusted	 for	covariates	 including	
age,	gender,	BMI,	smoking,	physical	activity,	diabetes	diagnosis	and	
treatment, based on previous studies.3‐6	 Associations	 with	 prev‐
alence of T2D and prediabetes outcome was analysed via logistic 
regression	models	adjusted	for	above	covariates	except	for	diabetes	
diagnosis and treatment.
Gene‐environment	 interactions	 between	 GRS	 tertiles	 and	 di‐
etary	components	on	HbA1c	were	analysed	via	separate	multivari‐
able	 linear	models	 (proc	GLM)	 including	 one	 interaction	 term	 per	
model:	HbA1c	=	GRS	+	interaction	variable	+	(GRS	*	interaction	vari‐
able)	+	covariates.	The	interaction	parameter	estimates	(beta‐coeffi‐
cients),	standard	errors,	95%	CI	and	P for interaction were reported. 
Models	were	adjusted	for	appropriate	covariates,	age,	gender,	BMI,	
alcohol, smoking, physical activity, mean energy intake, diabetes 
diagnosis and treatment, based on previous studies.9‐11 sas version 
9.4	(SAS	Institute	Inc	VX)	was	used	for	all	analysis.	Statistical	signifi‐
cance threshold was set at P < 0.05.
3  | RESULTS
Descriptive	statistics	of	the	sample	(n	=	14	089)	are	shown	in	Table	S1.	
The	GRS	was	not	associated	with	adiposity	markers	(BMI	or	waist	cir‐
cumference),	socio‐demographic	or	lifestyle	characteristics.	Differences	
across GRS were seen for prevalence of prediabetes and T2D.
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In	 multivariate	 analyses,	 GRS	 was	 associated	 with	 HbA1c.	
The	 estimated	 coefficient	 in	HbA1c	was	 0.03	 (95%	CI	 0.02,	 0.04)	
per	1	 (SD)	 increase	 in	 the	GRS	 (P	<	0.0001)	adjusted	 for	age,	 sex,	
BMI,	 smoking,	 physical	 activity,	 diabetes	 diagnosis	 and	 treatment	
(Table	1).	The	GRS	was	also	associated	with	prevalence	of	prediabe‐
tes	and	T2D.	The	OR	for	having	prediabetes	increased	by	9%	(95%	
CI	1.05‐1.13)	and	T2D	by	14%	(95%	CI	1.04‐1.24)	per	1	(SD)	increase	
in	the	GRS	(Table	2).
We observed significant interactions between GRS and intake of 
wholegrains P	for	interaction	0.04	(Table	3).	The	effect	of	the	diet	in‐
teractions	on	HbA1c	was	greater	in	high‐genetic‐risk	individuals	(GRS	
T2; β	=	−0.1%	per	100	g,	95%	CI	−0.1,	0.01,	GRS	T3;	β	=	−0.1%	per	
100	g,	95%	CI	−0.1,	0.01).	No	significant	interactions	were	observed	
for	the	other	dietary	variables.	All	models	were	adjusted	for	age,	sex,	
BMI,	smoking,	alcohol,	energy	intake,	physical	activity,	diabetes	diag‐
nosis and treatment. Sensitivity analyses showed that these diet ef‐
fect	modifications	on	HbA1c	were	similar	to	a	GRS	that	also	included	
SNPs	in	FTO	and	after	controlling	for	obesity	markers	(Table	S4).
There	was	a	significant	interaction	between	GRS	and	across	BMI	
categories.	We	observed	a	greater	effect	of	GRS	on	HbA1c	among	
obese	participants	(BMI	<30	kg/m2),	β	=	1.88%	(95%	CI	0.41,	3.34),	P 
for interaction 0.03. No interaction was observed for across alcohol 
consumption	group	(Table	4).
4  | DISCUSSION
In	this	large,	well‐characterized	occupational	cohort,	we	found,	among	
individuals of European ancestry at genetically high risk of diabetes, 
that	consuming	a	high‐quality	diet	and	high	wholegrain	intake	was	as‐
sociated with a beneficial modification of the genetic risk. This could 
have important future public health application in identifying geneti‐
cally	high‐risk	 individuals	before	the	onset	of	disease,	as	early	 inter‐
vention	may	help	slow	or	halt	the	development	of	T2D	and	CVD.26
We	 found	 attenuation	 of	 the	 genetic	 effect	 on	HbA1c	 among	
participants consuming a diet high in wholegrains, aligning with 
WHO's	dietary	guidelines	for	prevention	and	management	of	T2D.2 
The	diet	interactions	were	greater	in	higher‐risk	individuals	(persons	
in	the	two	highest	tertiles	for	GRS),	suggesting	that	such	individu‐
als may benefit more from maintaining a healthy diet. Similar find‐
ings were reported in individuals of European ancestry.2,27‐31 The 
Prevención	 con	 Dieta	 Mediterránea	 study	 (PREDIMED)	 analysing	
4.8‐year	 follow‐up	 data	 (n	 =	 7018).	 They	 observed	 interactions	
between	a	higher	diet	quality	 (Mediterranean	diet)	and	rs7903146	
SNP	(TCF7L2	gene)	 in	relation	to	fasting	glucose,27 supporting the 
suggestion that individuals of European ancestry at high genetic risk 
of	diabetes	consuming	a	high‐quality	diet	could	beneficially	modify	
their disease risk.
Interactions between wholegrains and single genetic variants 
on glycaemic trait and T2D risk have previously been reported. The 
European	Prospective	Investigation	of	Cancer	(EPIC)	study	reported	
that an interaction with wholegrain intake inversely modified the 
association	between	rs7903146	(TCF7L2	gene)	and	T2D	risk.31 The 
Malmö	Diet	and	Cancer	Study	(n	=	24	799)	showed	interactions	be‐
tween	intake	of	dietary	fibre	and	the	same	SNP	rs7903146	(TCF7L2)	
associated	with	32%	lower	T2D	incidence	among	participants	with	
the	 highest	 fibre	 intake	 (OR:	 1.24,	 95%	 CI	 1.04‐1.47)	 compared	
to	 those	 with	 lowest	 fibre	 intake	 (OR:	 1.56,	 95%	 CI	 1.31‐1.86,	
Pinteraction	 =	 0.05).
30 The same study reported a reduced effect of 
SNP	rs10423928	 (GIPR	gene)	on	T2D	 incidence	 in	 individuals	who	
had	the	highest	intake	of	carbohydrate	(OR	=	1.23,	95%	CI:	5%‐39%)	
compared	to	those	with	the	lowest	carbohydrate	intake	(OR	=	1.69,	
95%	 CI:	 29%‐86%).	 Our	 study	 did	 not	 observe	 any	 interaction	
with neither fibre nor carbohydrates despite these variables being 
highly	correlated	with	wholegrains.	However,	the	study	sample	size	
(n	=	3733)	was	significantly	smaller	sample	size	than	the	Malmö	Diet	
and	Cancer	Study	(n	=	24	799),	which	can	affect	power	in	such	in‐
teraction studies.
TA B L E  1  Genetic	score	association	with	HbA1c%	in	the	Airwave	Health	Monitoring	Study	(n	=	14	085)
 
Model 1a Model 2b Model 3c
β 95% CI P‐value β 95% CI P‐value β 95% CI P‐value
HbA1c	(%) 0.03 0.03, 0.05 <0.0001 0.03 0.03, 0.05 <0.0001 0.03 0.02, 0.04 <0.0001
Abbreviations:	CI,	confident	interval;	β,	beta‐coefficient.
aAdjusted	for	body	mass	index,	age	and	sex.	
bAdjusted	for	waist	circumference,	age	and	sex.	
cAdjusted	for	age,	sex,	body	mass	index,	smoking,	physical	activity,	diabetes	diagnosis	and	glucose	lowering	medication.	
 Cases/Subcohort ORa 95% CI P‐value
Prediabetesb 5253/8820 1.09 1.05, 1.13 <0.0001
Type 2 diabetesc 516/13	569 1.14 1.04, 1.24 0.006
Abbreviations:	95%	CI,	95%	confidence	interval;	OR,	odds	ratio.
aAdjusted	for	age,	sex,	BMI,	smoking,	physical	activity.	
bHbA1c	>	5.7	≤	6.5%	and	not	on	glucose	lowering	medication	or	previously	diagnosed	with	
diabetes. 
cHbA1c	≥6.5%	and/or	diagnosed	with	diabetes	and/or	glucose‐lowering	medication.	
TA B L E  2   Risk of prediabetes and type 
2	diabetes	by	per	one	point	(standardized)	
increase	in	genetic	score,	the	Airwave	
Health	Monitoring	Study	(n	=	14	085)
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The	modest	 protective	 effect	 of	 healthier	 diets	 on	HbA1c	 re‐
ported here, although not clinically important at an individual level, 
is valuable at a public health level, where a small change in the dis‐
tribution	of	HbA1c	would	result	in	a	population	reduction	in	future	
T2D.	The	UK	Prospective	Diabetes	study	(n	=	3642)	observed	that	
a	1%	reduction	in	HbA1c	was	associated	with	a	reduction	in	relative	
risk	of	T2D	of	21%	(95%	CI	12%‐24%),	number	of	CVD	complications	
(37%,	95%	CI	33%‐41%)	and	mortality	from	diabetes	(21%,	95%	CI	
15%‐27%).32
Finally,	 interactions	 were	 seen	 among	 obese	 individuals	 (BMI	
≥30	 kg/m2)	 with	 nearly	 twofold	 increase	 in	 HbA1c%,	 which	 is	 in	
line with previously reported findings.7,33	The	Prevención	con	Dieta	
Mediterranea	RCT	(n	=	7018)	also	reported	significant	interactions	
among obese participants.33
4.1 | Biological plausibility
This	cross‐sectional	study	cannot	delineate	the	mechanisms	under‐
lying the observed interactions. Several lines of evidence suggest 
that	such	interactions	between	these	T2D‐associated	genetic	vari‐
ants and nutrient groups are plausible. The beneficial bioactivities of 
a healthy diet such as balancing energy intake and intake of impor‐
tant nutritional components such as fibre and wholegrains regulate 
metabolic pathways associated with glycaemic control2; these may 
TA B L E  3  The	effect	of	genetic‐diet	interactions	on	HbA1c	across	genetic	risk	tertiles,	the	Airwave	Health	Monitoring	Study	(n	=	3733)
Dietary components
GRS tertile 1 GRS tertile 2 GRS tertile 3
Lowest risk
n = 1485
Highest risk
n = 1085 n = 1161
 βa 95% CI βa 95% CI Pinteraction
DRV	scoreb Ref −0.01 −0.02,	0.003 −0.01 −0.03,	0.01 0.15
Carbohydrates	(per	10	g) Ref −0.001 −0.01,	0.005 −0.04 −0.01,	0.002 0.41
Fibre	(per	10	g) Ref −0.02 −0.1,	0.1 −0.04 −0.1,	−0.004 0.71
Fruit,	vegetable	(per	
100	g)
Ref −0.02 −0.04,	−0.01 −0.01 −0.03,	0.01 0.12
Wholegrains	(per	100	g) Ref −0.1 −0.1,	0.01 −0.07 −0.1,	0.01 0.04
Total	fat	(per	10	g) Ref 0.005 −0.01,	0.02 0.01 −0.01,	0.03 0.64
Saturated	fat	(per	10	g) Ref 0.01 −0.03,	0.05 0.006 −0.03,	0.05 0.86
Added	sugars	(per	10	g) Ref −0.002 −0.01,	0.009 −0.006 −0.02,	0.01 0.55
Abbreviations:	CI,	confident	interval;	DRV,	dietary	reference	value	score;	GRS,	genetic	risk	score;	P interaction; P‐value	type	III	error;	β, 
beta‐coefficient.
aEstimated	effect	on	HbA1c%	per	increase	in	nutrient	variable	interaction	with	GRS	tertiles	adjusted	for	age,	gender,	smoking,	alcohol,	energy	intake,	
physical	activity,	BMI,	diabetes	diagnosis	and	treatment.	
bCoefficients	represent	per	1	point	increase	in	DRV	score.	
Interacting variables n
HbA1c (%)
Pinteractionβ
a 95% CI
Alcohol	categories
No alcohol intake 767 Ref  0.6
Within	UK	allowanceb 1670 −0.19 −1.57,	1.18
Above	UK	allowancec 1296 0.34 −1.08,	1.76
BMI	categories
BMI	(18.50‐24.99	kg/m2) 1273 Ref  0.03
BMI	(25‐29.99	kg/m2) 1741 0.11 −0.01,	1.22
BMI	(>30	kg/m2) 711 1.88 0.41, 3.34
Abbreviations:	Beta,	beta‐coefficient	interaction	effect;	BMI,	body	mass	index;	CI,	confident	inter‐
val;	HbA1c,	glycated	haemoglobin.
aBeta‐coefficient	for	the	estimated	difference	in	HbA1c%	per	unit	increase	in	genetic	risk	score	
interacting	with	alcohol	or	BMI	category	adjusted	for	age,	gender,	smoking,	physical	activity,	(BMI),	
(alcohol).	Note:	alcohol	included	in	BMI	model	and	BMI	in	alcohol	model.	
b>0	unit	and	<2	units	of	alcohol/d.	
c>2	units	of	alcohol/d.	
TA B L E  4   The effect of genetic 
interactions	on	HbA1c,	across	categories	
of alcohol consumption and body mass 
index,	the	Airwave	Health	Monitoring	
Study	(n	=	3733)
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partly	explain	the	modifying	effect	on	genetic	predisposition	to	high	
HbA1c	and	T2D	risk.	Proposed	mechanisms	from	high‐fibre	 intake	
(wholegrains)	may	involve	inhibition	of	a‐amylase,	and	slowdown	in	
intestinal transit times, leading to a prolongation and reduction of 
intestinal glucose absorption and thus to a lower postprandial insu‐
lin secretory demand. Fibre may also stimulate gastrointestinal hor‐
mone	secretion	of	gastric	 inhibitory	polypeptide	and	glucagon‐like	
peptide‐1	(GLP‐1).34	Variants	of	TCF7L2	 lead	to	impaired	GLP‐1‐in‐
duced	insulin	secretion	via	defects	in	GLP‐1	signalling	in	beta	cells35 
but	individuals	with	a	diet	high	in	fibre	(wholegrains)	may	counteract	
these genetic effects.
4.2 | Strengths and limitations of study
The	main	strength	of	this	study	is	the	extensive	dietary	data	collection	
(7‐day	food	diaries)	and	diet	profiling	on	a	large	sample	of	white	British	
population	(of	North	European	ancestry).	A	recent	study	from	EPIC‐
InterAct	did	not	find	interactions	between	a	T2D‐associated	GRS	and	
intake of eight macronutrients, but food frequency questionnaires, 
based on predefined food lists, were used for dietary data collection 
rather than more detailed prospective food records. Furthermore, it 
did not include a holistic diet profile incorporating diet quality and 
patterns, which was used in our study.14	 Another	 strength	 of	 this	
study	was	 the	 use	 of	 a	 comprehensive	 GRS	 (based	 on	 established	
markers),	which	has	the	advantage	over	single	markers	as	it	increases	
the power of the genetic prediction model.4,8 This is especially impor‐
tant	for	genetic	interaction	studies	where	effect	sizes	are	very	small.	
An	 important	 limitation	 is	 that	our	 study	design	does	not	allow	 for	
determination of the temporality of the observed associations, which 
is important when considering the longitudinal dimension of T2D de‐
velopment	and	 the	complexity	of	nutrient	and	genetic	 interactions.	
Another	 limitation	to	this	study	 is	 the	use	of	perspective	diet	qual‐
ity	profiling	in	epidemiological	study;	however,	given	the	lack	of	RCTs	
investigating differences in diet profile interactions with genetic risk, 
our study provides evidence to inform future intervention trials.
These findings need to be further evaluated and replicated in 
other settings applying the same method to confirm the interac‐
tion effects from diet and lifestyle on the genetic prediction of 
HbA1c.	Finally,	we	did	not	apply	stringent	control	for	the	limited	
number of multiple testing, and this may lead to potential over‐
statement	 of	 the	 findings.	 However,	 argument	 being	 that	 most	
of the nutritional variables are strongly correlated therefore not 
independent.
4.3 | Implications of findings and conclusion
The findings suggest that healthy weight and a diet high in who‐
legrains	may	help	counter	the	genetic	risk	of	elevating	HbA1c	and	
support recommendations for healthy diet and weight management 
as	part	of	public	health	prevention	of	T2D,	especially	in	high‐genetic‐
risk	groups.	Follow‐up	studies	and	RCTs	are	needed	to	support	these	
findings and to evaluate whether implementation of therapeutic 
dietary recommendations for people at high genetic risk may benefit 
from	a	“personalized	nutrition”	approach.
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